首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1169109

捨曲林鹽酸鹽市場：按類型、按應用、按分銷渠道、按地區 - 規模、份額、展望、機會分析，2022-2030 年

Sertraline HCl Market, by Type, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

出版日期: 2022年11月16日 | 出版商:

Coherent Market Insights | 英文 156 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

鹽酸捨曲林屬於一組稱為選擇性 5-羥色胺再攝取抑製劑 (SSRI) 的抗抑鬱藥。鹽酸捨曲林與其他 SSRI 具有相同的作用機制。它通過增加大腦中可用的血清素的量來起作用。血清素是一種神經遞質或化學信使，參與調節人日常生活的許多方面，包括情緒、睡眠、獎賞、學習和記憶。研究已將抑鬱症與血清素水平低聯繫起來。捨曲林增加大腦中血清素的含量，有助於扭轉化學失衡並改善人們的整體情緒。捨曲林可作為口服片劑或液體使用。一般來說，每天早上或晚上服用一次。那些用於治療經前煩躁症的可以每天服用或僅在每月的某些日子服用。

市場動態

主要市場趨勢包括抗抑鬱藥處方率和支出的增加，預計這將在預測期內推動市場增長。例如，根據 Springer Nature Switzerland AG 於 2021 年 3 月發表的一篇文章，在 COVID-19 流行期間（2020 年 1 月至 12 月）分發的 Ads（抗抑鬱藥）處方總數為 7800 萬，比 2020 年多 400 萬2019 年，英國公共資助的醫療保健系統國民醫療服務體系 (NHS) 比 2019 年增加了 1.39 億英鎊（約合 1.707 億美元）。 2020 年僅 SSRI 抗抑鬱藥捨曲林就比 2019 年增加了 1.13 億英鎊（1.387 億美元）。

本研究的主要特點

本報告對全球鹽酸捨曲林市場進行了深入分析，顯示了以 2021 年為基準年的預測期（2022-2030 年）的市場規模（百萬美元）和復合年增長率 (CAGR%) . 它提供。
解釋了不同細分市場的潛在創收機會，並描述了針對該市場的有吸引力的投資建議矩陣。
它還提供有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
它根據以下參數介紹了全球鹽酸捨曲林市場的主要參與者 - 公司概況、產品組合、主要亮點、財務業績和戰略。
本研究涵蓋的主要公司包括輝瑞公司、Teva Pharmaceutical Industries Ltd.、Novartis AG、Accord Biopharma、Apotex Inc.、Aurobindo Pharma USA、InvaGen、Lupin、Camber Pharmaceuticals、Mylan（Viatris Inc 的一部分） .), Sun Pharmaceutical, Wockhardt, Alpic Biotech
這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。我猜。
本報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者可以通過用於分析全球鹽酸捨曲林市場的各種戰略矩陣來促進他們的決策。

內容

第 1 章目的和先決條件

調查目的
先決條件
縮寫說明

第二章市場展望

報告內容
- 市場定義和範圍
執行摘要
- 市場概況：按類型分類
- 市場概況：按應用分類
- 市場概況：按分銷渠道
- 市場概況：按地區
連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

市場動態
- 司機
- 約束因素
- 商機
影響分析
監管場景
市場趨勢
主要發展狀況
流行病學
害蟲分析
合作夥伴關係和收購
搬運工分析
管道分析

第 4 章鹽酸捨曲林全球市場 - 冠狀病毒 (COVID-19) 大流行的影響

經濟影響
對供需的影響
COVID-19 影響評估

第 5 章全球鹽酸捨曲林市場類型，2017-2030

25毫克
50 毫克
100 毫克
其他

第 6 章。2017-2030 年全球鹽酸捨曲林市場應用情況

強迫症
抑鬱症
恐慌症
經前煩躁症
其他

第 7 章。全球鹽酸捨曲林市場：按分銷渠道，2017-2030

醫院藥房
零售藥房
在線藥店

第 8 章 2017-2030 年全球各地區鹽酸捨曲林市場

北美
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
其他拉丁美洲地區
歐洲
英國
德國
法國
意大利
西班牙
俄羅斯
其他歐洲
亞太地區
中國
印度
日本
澳大利亞
韓國
東盟
其他亞太地區
中東
海灣合作委員會
以色列
其他中東地區
非洲
北非
中非
南非

第9章競爭格局

熱圖分析
市場份額分析
- Pfizer
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Accord Biopharma
- Apotex Inc.
- Aurobindo Pharma USA
- InvaGen
- Lupin
- Camber Pharmaceuticals
- Mylan N.V.（a part of Viatris Inc.）
- Sun Pharmaceutical
- Wockhardt
- Alpic Biotech

第 10 章

調查方法介紹
關於出版商

簡介目錄

Product Code: CMI5355

Sertraline HCl belongs to a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). Sertraline HCl has the same mechanism of action as other SSRIs. It works by increasing the amount of serotonin that is available in the brain. Serotonin is a neurotransmitter, or chemical messenger, that is involved in regulating many elements of a person's daily life, including mood, sleep, rewards, learning, and memory. Research has linked depression with low levels of serotonin. Sertraline increases the amount of serotonin present in the brain, helping to reduce chemical imbalances and improve a person's overall mood. Sertraline is available as either an oral tablet or a liquid. Typically, a person takes a dose in the morning or evening, once a day. People using it to treat premenstrual dysphoric disorder may take it every day or only on select days of the month.

Market Dynamics

Key trends in the market include increasing prescription rate and expenditure for antidepressant drug which is expected to drive the market growth during the forecast period. For instance, according to an article published in Springer Nature Switzerland AG in March 2021, stated that the total number of Ads (antidepressants) prescriptions dispensed during COVID-19 pandemic (January to December 2020) were 78 million, 4 million more than in 2019 that costed the National Health Service (NHS) is the publicly funded healthcare system in England, £139 million (US $170.7 million) more than in 2019. Sertraline, an SSRI antidepressant drug, alone accounted for an extra £113 million (US $ 138.7 million) during 2020 than in 2019.

Key features of the study:

This report provides an in-depth analysis of the global sertraline HCl market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global sertraline HCl market based on the following parameters - Company Highlights, Products Portfolio, Key Highlights, Financial Performance, Strategies
Key companies covered as a part of this study include Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Accord Biopharma, Apotex Inc., Aurobindo Pharma USA, InvaGen, Lupin, Camber Pharmaceuticals, Mylan (a part of Viatris Inc.), Sun Pharmaceutical, Wockhardt, Alpic Biotech
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global sertraline HCl market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sertraline HCl market.

Detailed Segmentation:

Global Sertraline HCl Market, By Type:
- 25 mg
- 50 mg
- 100 mg
- Others
Global Sertraline HCl Market, By Application:
- Obsessive-Compulsive Disorder
- Depression
- Panic Disorder
- Premenstrual Dysphoric Disorder
- Others
Global Sertraline HCl Market, By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Sertraline HCl Market, By Region:
- North America
  - By Country
- U.S.
- Canada
- Latin America
  - By Country
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
  - By Country
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
  - By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
  - By Country
- GCC
- Israel
- Rest of Middle East
- Africa
  - By Country
- South Africa
- Central Africa
- North Africa
Company Profiles
- Pfizer Inc *
  - Company Highlights
  - Products Portfolio
  - Key Highlights
  - Financial Performance
  - Strategies
- Teva Pharmaceutical Industries Ltd.,
- Novartis AG
- Accord Biopharma
- Apotex Inc.,
- Aurobindo Pharma USA
- InvaGen
- Lupin
- Camber Pharmaceuticals
- Mylan N.V. (a part of Viatris Inc.)
- Sun Pharmaceutical
- Wockhardt
- Alpic Biotech

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunity
Impact Analysis
Regulatory Scenario
Market Trends
Key Developments
Epidemiology
PEST Analysis
Collaboration and Acquisition
Porters Analysis
Pipeline Analysis

4. Global Sertraline HCl Market- Impact of Coronavirus (COVID-19) Pandemic

Economic Impact
Impact on Demand and Supply
COVID-19 Impact Assessments

5. Global Sertraline HCl Market, By Type, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
25 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
50 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
100 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Mn)

6. Global Sertraline HCl Market, By Application, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Obsessive-Compulsive Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Depression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Panic Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Premenstrual Dysphoric Disorder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

7. Global Sertraline HCl Market, By Distribution channel, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2017 - 2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Million)

8. Global Sertraline HCl Market, By Region, 2017-2030, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
U.K.
Germany
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017-2030,(US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2030,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017-2030,(US$ Mn)
North Africa
Central Africa
South Africa